SCHEMBL6599224

SCHEMBL6599224

Nc1nc2ccc[c]c2[nH]1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.48
NUDT1 P36639 2/20 0.48
MASP2 O00187 1/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
AOC3 Q16853 1/20 0.48
QTRT1 Q9BXR0 1/20 0.43
PLAU P00749 1/20 0.35
HTR3E A5X5Y0 1/20 0.35
HTR3B O95264 1/20 0.35
HTR3A P46098 1/20 0.35
BACE1 P56817 1/20 0.35
HTR3D Q70Z44 1/20 0.35
HTR3C Q8WXA8 1/20 0.35
TYMS P04818 8/20 0.34
FABP6 P51161 2/20 0.33
KDM4E B2RXH2 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16097277 0.76 PARP1 (0.43) ALDH1A1MEN1KMT2ATYMSKDM4E
SCHEMBL4639811 0.72 POLB (0.37) ALDH1A1MEN1KMT2AKDM4EGAA
SCHEMBL694986 0.72 NPC1 (0.55) ALDH1A1MEN1KMT2AKDM4EGAA
SCHEMBL694946 0.69 PKN1 (0.56) ALDH1A1KDM4EGAAMAPTHPGD
SCHEMBL3499660 0.68 NUDT1 (0.48) ALDH1A1NUDT1MASP2MEN1KMT2A
SCHEMBL694892 0.67 ALOX5 (0.48) ALDH1A1MEN1KMT2AKDM4EGAA
SCHEMBL5539351 0.67 PDGFRB (0.39) ALDH1A1KDM4EGAA
SCHEMBL5541674 0.67 ALDH1A1 (0.58) ALDH1A1MEN1KMT2AKDM4EGAA
SCHEMBL695165 0.66 GAA (0.44) KMT2AKDM4EGAAMAPT
SCHEMBL30587443 0.66 ALDH1A1 (1.00) ALDH1A1NUDT1MASP2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1385833-A1 TRIAZINYL AMIDE DERIVATIVES AS ANGIOGENESIS INHIBITORS Amgen Inc. (US) 2004-02-04 EP disclosed
WO-2002083654-A1 TRIAZINYL AMIDE DERIVATIVES AS ANGIOGENESIS INHIBITORS AMGEN INC. (US) 2002-10-24 WO disclosed